Recombinate
RECOMBINATE [Antihemophilic Factor (Recombinant)]
Approved
Approval ID
d74e59ba-bfeb-4c48-9596-da44328561a9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 26, 2010
Manufacturers
FDA
Baxter Healthcare Corporation
DUNS: 039121363
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Antihemophilic Factor Recombinant
PRODUCT DETAILS
NDC Product Code0944-2843
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationN/A
Effective DateJune 15, 2006
Generic NameAntihemophilic Factor Recombinant
Antihemophilic Factor Recombinant
PRODUCT DETAILS
NDC Product Code0944-2842
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationN/A
Effective DateJune 15, 2006
Generic NameAntihemophilic Factor Recombinant
Antihemophilic Factor Recombinant
PRODUCT DETAILS
NDC Product Code0944-2841
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationN/A
Effective DateJune 15, 2006
Generic NameAntihemophilic Factor Recombinant